R03DC Leukotriene receptor antagonists for obstructive airway diseases
ATC group of level 4 – chemical subgroup · in plain English: tablets for asthma and COPD
This site has the patient leaflet or the SPC of 22 medicines in this group and its subgroups.
- 15 prescription only (POM)
- 7 no longer supplied or not available
Active substance: Montelukast – all medicines with this substance, also in combinations.
Place in the ATC classification
- R Respiratory system drugs 803 medicines
- R03 Drugs for obstructive airway diseases 396 medicines
- R03D Other systemic drugs for obstructive airway diseases 60 medicines
-
R03DC Leukotriene receptor antagonists for obstructive airway diseases 22 medicines
- R03DC03 montelukast 22 medicines
-
R03DC Leukotriene receptor antagonists for obstructive airway diseases 22 medicines
- R03D Other systemic drugs for obstructive airway diseases 60 medicines
- R03 Drugs for obstructive airway diseases 396 medicines
4 more subgroups have no medicine with a leaflet on this site.
Medicines in the group and its subgroups
Other groups of the same level
Other names of the ATC group
- Czech: R03DC Antagonisté leukotrienových receptorů
- French: R03DC antagonistes des récepteurs aux leucotriènes
- German: R03DC Leukotrienrezeptorantagonisten
- Spanish: R03DC ANTAGONISTAS RECEPTORES DEL LEUKOTRIENO (ANTIASMATICOS)
- German: R03DC Leukotrienrezeptorantagonisten
- Italian: R03DC Antagonisti dei recettori leucotrienici
- Polish: R03DC Antagoniści receptora leukotrienowego
- Turkish: R03DC Obstrüktif hava yolu hastalıkları için lökotrien reseptör antagonistleri
- Portuguese (Brazil): R03DC Antagonistas dos receptores dos leucotrienos
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group R03DC
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
